Recent news on

New TNS(R) Serum From SkinMedica(R) Exclusively Applied Through ...  -  Apr 24, 2007
PR Newswire (press release),VANIQA(R) (eflornithine hydrochloride) Cream, 13.9%, is the only FDA-approved prescription product for the treatment of unwanted facial hair in women;

Hormones and the Skin: The Role Hormones Play As We Age  -  Apr 12, 2007
Drug Newswire (press release),Hirsutism can be treated with topical treatments, such as eflornithine cream, as well as many modes of hair removal including waxing, shaving and laser

Polycystic ovary syndrome in adolescence associated with obesity  -  Mar 30, 2007
AAP News (subscription)Eflornithine hydrochloride cream or laser therapies are local dermatologic measures that are effective for small areas of hirsutism.

Uganda: Over 9m people at risk getting sleeping sickness-scientists  -  Mar 13, 2007
SomaliNet..."One of the serious constraints is that drugs [available for treating sleeping sickness] are old and toxic, particularly melarsoprol and eflornithine.

Stress kills sleeping sickness parasites  -  Mar 9, 2007
DrugResearcher.com,...of charge to endemic countries through a WHO private partnership with Sanofi-Aventis (pentamidine, melarsoprol and eflornithine) and Bayer (suramin).

Barrier Therapeutics Receives Regulatory Approval to Market ...  -  Mar 8, 2007
Genetic Engineering News (press release),The marketing and sales organization currently markets three pharmaceutical products in Canada: VANIQA(R) (eflornithine hydrochloride) Cream 13.9% for

Health Watch: Unwanted hair in women  -  Feb 8, 2007
Ithaca Journal,Finally there is a cream that has been developed for use in women with unwanted hair called Eflornithine. This is applied directly to the areas affected by

SkinMedica(R) Announces Commercial Launch of Desonate(TM ...  -  Feb 12, 2007
PR Newswire (press release),VANIQA(R) (eflornithine hydrochloride) Cream, 13.9%, is the only FDA-approved prescription product for the treatment of unwanted facial hair in women;

SHIRE PLC: Final Results  -  Feb 20, 2007
FinanzNachrichten.de,...gel diclofenac sodium (3%w/w)) VANIQA® (eflornithine hydrochloride) VYVANSE™ (lisdexamfetamine dimesylate) XAGRID® (anagrelide hydrochloride) The

Shire plc: On Time Execution of Operating Plan Delivers Strong ...  -  Feb 20, 2007
PR Newswire (press release),...gel diclofenac sodium (3%w/w)) VANIQA(R) (eflornithine hydrochloride) VYVANSE(TM) (lisdexamfetamine dimesylate) XAGRID(R) (anagrelide hydrochloride) The

Promising Drug Combinations For Sleeping Sickness: New Treatments ...  -  Dec 27, 2006
Medical News Today (press release),In the trial, the cure rate for nifurtimox-eflornithine was over twice that for melarsoprol-nifurtimox and substantially higher than that for

Congo-Kinshasa: Calls for Fast Access to Sleeping Sickness Drug  -  Jan 11, 2007
AllAfrica.com,The trials test the effectiveness of combining two drugs, eflornithine and nifurtimox, against sleeping sickness. Trials began in Congo-Brazzaville and have

SkinMedica Launches NeoBenz(R) Micro SD for Acne  -  Jan 8, 2007
PR Newswire (press release),SkinMedica's EpiQuin(R) Micro (4% Hydroquinone) treats melasma and postinflammatory hyperpigmentation; VANIQA(R) (eflornithine hydrochloride) Cream, 13.9%,

Promising Drug Combinations For Sleeping Sickness  -  Dec 13, 2006
Medical News Today (press release),In the trial, the cure rate for nifurtimox-eflornithine was over twice that for melarsoprol-nifurtimox and substantially higher than that for

Drug Pushers, Inc: Profit and Power in the Legal Drug Trade  -  Dec 8, 2006
Infoshop NewsThe more effective treatment is eflornithine, which was discontinued as a treatment for sleeping sickness by Aventis because it was unprofitable.

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional